«Rejecting modern technologies on non-scientific
grounds sets a dangerous precedent for the internal market and sends a negative signal for innovative industries worldwide considering whether or not to invest and operate in Europe,» said Beat Späth, director for agricultural biotechnology at the industry association EuropaBio here, in a statement today.